(XHE) SPDR S&P Health Care - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US78464A5810 • Health

XHE: Medical, Devices, Equipment, Supplies, Diagnostics, Instruments

The SPDR® S&P Health Care Equipment ETF (NYSE Arca:XHE) is designed to track the performance of the S&P Health Care Equipment Select Industry Index, which is a subset of the S&P Total Market Index (S&P TMI). The fund uses a sampling strategy to achieve this, meaning it invests in a representative portfolio of securities that closely replicates the indexs performance rather than holding every single security. It allocates at least 80% of its total assets to securities included in the index, with the remainder potentially invested in other securities. The index itself focuses on companies in the health care equipment sector, particularly those involved in the manufacturing of medical devices, equipment, and related products.

The funds technical indicators suggest a bearish outlook. The last price of 88.55 is below both the 20-day (91.93) and 50-day (91.64) simple moving averages (SMA), indicating downward momentum. The 200-day SMA (88.64) is slightly above the current price, suggesting potential resistance. The Average True Range (ATR) of 1.36 indicates moderate volatility. With an average volume of 13,367 shares over the past 20 days, liquidity is relatively low compared to larger ETFs. The funds assets under management (AUS) of $209.90M reflect its niche focus on the health care equipment sector.

Based on the technical and fundamental data, the ETF is expected to face continued downward pressure over the next three months. The price is likely to remain below the 200-day SMA, potentially testing support levels near 86.00. The relatively low AUM and sector-specific focus may limit upside potential, making the fund vulnerable to broader market declines.

Additional Sources for XHE ETF

XHE ETF Overview

Market Cap in USD 193m
Category Health
TER 0.35%
IPO / Inception 2011-01-26

XHE ETF Ratings

Growth 5y 8.17%
Fundamental -
Dividend 35.7%
Rel. Strength Industry -11.5
Analysts -
Fair Price Momentum 72.49 USD
Fair Price DCF -

XHE Dividends

Dividend Yield 12m 0.04%
Yield on Cost 5y 0.05%
Annual Growth 5y 100.00%
Payout Consistency 45.0%

XHE Growth Ratios

Growth Correlation 3m -22%
Growth Correlation 12m 71.5%
Growth Correlation 5y -47.9%
CAGR 5y 4.63%
CAGR/Max DD 5y 0.09
Sharpe Ratio 12m 0.57
Alpha -11.31
Beta 0.71
Volatility 23.12%
Current Volume 8.5k
Average Volume 20d 11.3k
What is the price of XHE stocks?
As of March 14, 2025, the stock is trading at USD 81.05 with a total of 8,508 shares traded.
Over the past week, the price has changed by -4.91%, over one month by -11.66%, over three months by -11.37% and over the past year by -4.25%.
Is SPDR S&P Health Care a good stock to buy?
Neither. Based on ValueRay Analyses, SPDR S&P Health Care is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 8.17 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XHE as of March 2025 is 72.49. This means that XHE is currently overvalued and has a potential downside of -10.56%.
Is XHE a buy, sell or hold?
SPDR S&P Health Care has no consensus analysts rating.
What are the forecast for XHE stock price target?
According to ValueRays Forecast Model, XHE SPDR S&P Health Care will be worth about 80.6 in March 2026. The stock is currently trading at 81.05. This means that the stock has a potential downside of -0.56%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 80.6 -0.6%